Rated 4.98-stars across 4.8K+ reviews
Rated 4.98-stars across 3.9K+ reviews Rated 4.98-stars across 3.9K+ reviews Rated 4.98-stars across 3.9K+ reviews Rated 4.98-stars across 3.9K+ reviews Rated 4.98-stars across 3.9K+ reviews

Can Your DNA Predict Heart Disease Risk Best? Two New 2026 JACC Studies

Dr. Kaet (Lukkaet Laoprapaipan) profile image By
Dr. Kaet (Lukkaet Laoprapaipan)
|
Nov 21, 2026
|
56
Health
Genetics
Research
genetics and heart disease risk
Summary
genetics and heart disease risk

Two large 2026 studies in JACC, covering over 215,000 and 245,000 people, found that a genetic (polygenic) risk score was the strongest predictor of coronary artery disease — and sharpest when combined with inflammation, LDL and Lp(a).

Hi, I'm Dr. Kaet. In my work in genetics and preventive medicine, one question I hear a lot is: "Isn't a cholesterol blood test enough, doctor? Why look all the way down to the DNA?" In 2026, two large studies published in the Journal of the American College of Cardiology (JACC) answered this far more clearly than before, and the result is more striking than many expect: among all the heart-risk measures we have, genetics stood out in a remarkable way. In this article I'll walk you through what the studies found and what it means for taking care of your heart.

New 2026 research: when "genes" are the strongest predictor

The first study, from the UK Biobank, analyzed over 215,000 participants, led by Dr. Akl Fahed and Dr. Paul Ridker. The team compared four coronary artery disease risk measures in the same group of people: a genetic (DNA-based or polygenic) risk score, the inflammation marker hsCRP, LDL cholesterol, and Lipoprotein(a), or Lp(a).

The result is fascinating. Among all four, the genetic risk score had the strongest association with developing coronary artery disease in the future. Another notable point: the inflammation marker hsCRP was associated with risk slightly more strongly than LDL.

Why does genetics stand out? In principle, our genes are with us from birth and don't change with age, whereas cholesterol or inflammation are snapshots at a single point in time that rise and fall. A genetic score therefore reflects a "baseline tendency" that has been accumulating across a lifetime, even before blood values start to go off track.

The real power is in "combining"

Although the headline says genetics was the strongest, the most important conclusion of this study was not about crowning a single winner. The team found that when all four measures were combined — genetics, inflammation, LDL and Lp(a) — they gave a clearer, more complete picture of risk than any one measure alone.

The reason is that each one reports on a different side of the heart's biology. Genetics signals an inherited tendency, LDL reflects the amount of circulating cholesterol, hsCRP indicates the level of inflammation in the vessels, and Lp(a) is another often-overlooked inherited risk factor. Looking from several angles at once is like seeing a sharper photograph rather than guessing from a single dot. This is the heart of what's called multi-factor risk assessment, in which genetics is one piece that fills in the picture well.

Combining genetics, inflammation, LDL and Lp(a) to assess heart disease risk
Combining genetics, inflammation (hsCRP), LDL and Lp(a) gives a clearer picture of heart risk than any single measure alone.

More evidence: predicting 8 heart conditions in over 245,000 people

The second study came from the All of Us Research Program in the United States, analyzing over 245,000 participants. The team developed genetic risk scores for eight cardiovascular conditions, including coronary artery disease, and then validated their accuracy again in the Mass General Brigham Biobank.

What this study reflects is that the polygenic risk score (PRS) is moving from a "research tool" closer to a "report that can be used in the clinic." Building a single report that covers several conditions at once and holds up across different health systems is an important step toward making genetic information genuinely usable. If you'd like to understand the basics of how these scores are calculated, I've explained it in What is a Polygenic Risk Score (PRS) and the research behind it in GWAS.

What this means for your heart

What I most want people to take from these two studies is a new perspective: part of your heart disease risk is written in your DNA before any symptoms appear. The advantage of genetics is that it can be known early — you don't have to wait for cholesterol or blood pressure to rise first. That means knowing your own genetic tendency can be a head start on prevention.

Adjusting lifestyle to prevent heart disease after learning genetic risk
Knowing your risk early means starting prevention early — genetics is not destiny, and lifestyle still changes the final outcome.

This is why genetic testing like Geneus DNA has value as one "supporting piece" of information. It helps you and your doctor see risk that may be hidden, so you can plan screening and health care more precisely — much as a gene like APOE plays a role in managing cholesterol.

But the best news is that genetics is not destiny. A high risk score does not mean you will certainly develop disease. Eating well, exercising, not smoking, and controlling blood pressure and cholesterol still have enormous power to change the final outcome. Knowing you're at higher risk should be a nudge to start caring for yourself sooner — not a cause for worry.

Read it wisely: limitations to know

To be fair to the data, I'd like you to read this section before interpreting your own score.

First, these studies describe an "association," not a diagnosis or a definitive individual prediction. A genetic score tells you a statistical tendency across a group; it does not tell you whether or when you will develop disease. Second, most of the genetic data used to build these scores comes from people of European ancestry, so accuracy may be lower in Asians, including Thais — interpret with care. Third, a genetic score is only one of several factors that must always be considered alongside family history, blood values, and lifestyle.

My conclusion as a physician is that genetic information is a valuable tool for "proactive prevention," but it does not replace medical check-ups or a doctor's advice. If your test shows a high risk, the right thing to do is take the result to your doctor to plan together — not to make treatment decisions on your own from a score alone.

1. Does a high genetic risk score mean I will definitely get heart disease?

No. A genetic score shows a statistical tendency, not a diagnosis or a definitive individual verdict. Many people with high scores never develop disease, because lifestyle and environment play a large role. A high score is a signal to start caring for yourself sooner and to consult your doctor — not a cause for worry.

2. If I already test my LDL cholesterol, why look at genetics too?

Because genes are with you from birth and reflect a baseline tendency before blood values go off track. The 2026 UK Biobank study found the genetic score had the strongest association with coronary artery disease among four measures, and gave the clearest picture when combined with LDL, inflammation and Lp(a). They complement each other rather than replace one another.

3. How accurate is a genetic risk score for Thai people?

Interpret it with care. Most of the genetic data used to build these scores comes from people of European ancestry, so accuracy may be lower in Asians, including Thais. It should be viewed as supporting information used alongside family history and other tests, not a final answer on its own.

4. What should I do if I find out I have a high genetic risk?

Don't panic. Take the result to your doctor to assess alongside your family history and other risk factors, then plan appropriate screening. Most importantly, adopt preventive lifestyle changes — diet, exercise, not smoking, and controlling blood pressure and cholesterol — because behavior still has a major effect on the final outcome.

References

  1. Fahed AC, Ridker PM, et al. Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study. Journal of the American College of Cardiology. 2026. jacc.org
  2. Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions. Journal of the American College of Cardiology. 2026. jacc.org
  3. Mass General Brigham. Validation Study Reveals New Tool Can Predict Patients' Genetic Risk of Eight Cardiovascular Conditions. 2026. eurekalert.org
  4. TCTMD. Genomics, Lipids, Inflammation at Midlife Predict Future CAD. 2026. tctmd.com
Written by Dr. Kaet (Lukkaet Laoprapaipan)
chat whatsapp chat line chat facebook